Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Read more: https://techcrunch.com/2026/09/23/enveda-secures-3...
Scan with your phone
Scan with your phone